%0 Journal Article %1 Lagakos2006 %A Lagakos, Stephen W %D 2006 %J The New England journal of medicine %K AdenomatousPolyps AdenomatousPolyps:prevention&control Cyclooxygenase2Inhibitors Cyclooxygenase2Inhibitors:adverseeffects DataInterpretation Follow-UpStudies Humans Lactones Lactones:adverseeffects ProportionalHazardsModels Risk Statistical Sulfones Sulfones:adverseeffects SurvivalAnalysis Thrombosis Thrombosis:chemicallyinduced TimeFactors RCT %N 2 %P 113-7 %R 10.1056/NEJMp068137 %T Time-to-event analyses for long-term treatments--the APPROVe trial. %U http://www.ncbi.nlm.nih.gov/pubmed/16801354 %V 355 %@ 1533-4406

@article{Lagakos2006, added-at = {2023-02-03T11:44:35.000+0100}, author = {Lagakos, Stephen W}, biburl = {https://www.bibsonomy.org/bibtex/2d8bcf52284682de3f6326935b54a6bf7/jepcastel}, city = {Harvard School of Public Health, Boston, USA.}, doi = {10.1056/NEJMp068137}, interhash = {0a73bf0bdaa1a4aae1bd367789f56597}, intrahash = {d8bcf52284682de3f6326935b54a6bf7}, isbn = {1533-4406}, issn = {1533-4406}, journal = {The New England journal of medicine}, keywords = {AdenomatousPolyps AdenomatousPolyps:prevention&control Cyclooxygenase2Inhibitors Cyclooxygenase2Inhibitors:adverseeffects DataInterpretation Follow-UpStudies Humans Lactones Lactones:adverseeffects ProportionalHazardsModels Risk Statistical Sulfones Sulfones:adverseeffects SurvivalAnalysis Thrombosis Thrombosis:chemicallyinduced TimeFactors RCT}, month = {7}, note = {4860<m:linebreak></m:linebreak>LR: 20071115; JID: 0255562; 0 (Cyclooxygenase 2 Inhibitors); 0 (Lactones); 0 (Sulfones); 0 (rofecoxib); CON: N Engl J Med. 2005 Mar 17;352(11):1092-102. PMID: 15713943; 2006/06/26 [aheadofprint]; ppublish;<m:linebreak></m:linebreak>Anàlisi de supervivència}, number = 2, pages = {113-7}, pmid = {16801354}, timestamp = {2023-05-04T08:59:38.000+0200}, title = {Time-to-event analyses for long-term treatments--the APPROVe trial.}, url = {http://www.ncbi.nlm.nih.gov/pubmed/16801354}, volume = 355, year = 2006 }